Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
4
×
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
4
×
biotech
boston blog main
boston top stories
clinical trials
national
national top stories
pfizer
alzheimer's disease
biotech ipos
boulder/denver blog main
boulder/denver top stories
cancer drugs
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
investing
medical device
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle genetics
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
What
week
4
×
bio
biotech
companies
drug
ipo
life
roundup
science
street
wall
way
welcomed
acquisitions
aducanumab
alzheimer’s
amyloid
angst
arrival
bagged
biggest
billions
biogen
biogen’s
boost
brammer
build
buy
ceo
company’s
daniel
days
debut
dyne’s
effects
failure
felt
followed
genomics
gilead
Language
unset
Current search:
week
×
" san francisco top stories "
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
